Cognex Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.1B+19.1% YoYTTM through 5 Jul 2026
Net Income $174.8M+64.6% YoYTTM through 5 Jul 2026
Free Cash Flow $268.3MTTM through 5 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 71.1% |
| EBITDA Margin | 23.0% |
| Operating Margin | 22.3% |
| Net Margin | 16.1% |
Returns
10.7%ROE
8.0%ROA
13.2%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio3.64x
Net Debt-$296.8Mnet cash position
Cash & Equivalents$302.5M
Quality Metrics
Altman Z-Score12.31
Piotroski F-Score8 / 9
FCF Margin24.6%
Rule of 4029.8
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $994.4M
Diluted EPS$1.04TTMFY2025: $0.68
Dividend
$0.26Per share, FY20260.43%Yield-34.9%5-yr growth
Capital Allocation
R&D Spend$140.6M
Capex Intensity0.8%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.